instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Streptococcal urinary tract infection'? | A Rare Case of Severe Lactic Acidosis from 5-Fluorouracil after mFOLFOX6 Treatment in a Patient with Advanced Gastric Cancer.
Gastric cancer is one of the most common cancers worldwide and is one of the deadliest types of neoplasm. Many patients present with an advanced stage where palliative chemotherapy is the standa... | Recovered | ReactionOutcome | CC BY-NC | 33976632 | 19,173,917 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypofibrinogenaemia'. | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976633 | 19,461,375 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | METHYLPREDNISOLONE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | Oral | DrugAdministrationRoute | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | PULSE THERAPY | DrugDosageText | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the outcome of reaction 'Hypofibrinogenaemia'? | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | Recovered | ReactionOutcome | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the outcome of reaction 'Thrombocytopenia'? | Vasculitis and Breast Cancer: Mind the Hint.
Diffuse alveolar haemorrhage related to an anti-neutrophil cytoplasmic antibody (ANCA)-associated small vessel vasculitis is an extremely rare form of presentation of breast cancer. Here we report the case of a 77-year-old woman with a histological diagnosis of a papillary d... | Recovered | ReactionOutcome | CC BY-NC | 33976633 | 19,461,375 | 2021 |
What was the outcome of reaction 'Acute generalised exanthematous pustulosis'? | Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer.
Acute generalized exanthematous pustulosis (AGEP) is a rare drug-related adverse skin reaction caused mainly by antibiotics. Erlotinib is an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) used to treat l... | Recovered | ReactionOutcome | CC BY-NC | 33976640 | 19,721,672 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, LEUPROLIDE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 20,163,026 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, LEUPROLIDE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 20,163,026 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, LEUPROLIDE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 20,163,026 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, PREDNISONE | DrugsGivenReaction | CC BY-NC | 33976646 | 20,139,532 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, ENZALUTAMIDE, LEUPROLIDE ACETATE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 19,753,224 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Oedema'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, LEUPROLIDE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 20,163,026 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, LEUPROLIDE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 20,163,026 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prostatic specific antigen increased'. | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | ABIRATERONE, BICALUTAMIDE, ENZALUTAMIDE, LEUPROLIDE ACETATE, PREDNISONE, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY-NC | 33976646 | 19,753,224 | 2021 |
What was the outcome of reaction 'Fatigue'? | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | Recovering | ReactionOutcome | CC BY-NC | 33976646 | 19,753,224 | 2021 |
What was the outcome of reaction 'Prostatic specific antigen increased'? | Stunning Response with Low-Dose Enzalutamide after Abiraterone Acetate Failure in a Patient Diagnosed with Metastatic Castration-Resistant Prostate Cancer: A Case Report.
We report a case of an elderly patient with metastatic castration-resistant prostate cancer, initially treated with abiraterone acetate (1,000 mg/day... | Recovered | ReactionOutcome | CC BY-NC | 33976646 | 19,753,224 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature.
Two cases of primary distal femur osteosarcoma with subsequent metastasis to the abdomen are presented. In both cases, the development of abdominal metastasis was quickly followed by patient decline and death. A review of t... | CISPLATIN, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE SODIUM | DrugsGivenReaction | CC BY-NC | 33976648 | 19,955,941 | 2021 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Metastasis of Osteosarcoma to the Abdomen: A Report of Two Cases and a Review of the Literature.
Two cases of primary distal femur osteosarcoma with subsequent metastasis to the abdomen are presented. In both cases, the development of abdominal metastasis was quickly followed by patient decline and death. A review of t... | HIGH-DOSE | DrugDosageText | CC BY-NC | 33976648 | 19,955,941 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | ETHAMBUTOL HYDROCHLORIDE, ICOTINIB, ISONIAZID, PEMETREXED, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 33976649 | 19,942,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | ETHAMBUTOL HYDROCHLORIDE, ICOTINIB, ISONIAZID, PEMETREXED, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 33976649 | 19,942,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to adrenals'. | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | ETHAMBUTOL HYDROCHLORIDE, ICOTINIB, ISONIAZID, PEMETREXED, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 33976649 | 19,942,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | ETHAMBUTOL HYDROCHLORIDE, ICOTINIB, ISONIAZID, PEMETREXED, PYRAZINAMIDE, RIFAMPIN | DrugsGivenReaction | CC BY-NC | 33976649 | 19,942,359 | 2021 |
What was the administration route of drug 'ICOTINIB'? | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | Oral | DrugAdministrationRoute | CC BY-NC | 33976649 | 19,942,359 | 2021 |
What was the dosage of drug 'PEMETREXED'? | A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient.
The coexistence of lung cancer and pulmonary tuberculosis (TB) is rare, and the clinical and radiological features are always similar between lung cancer and pulmonary TB. In the present cas... | UNK UNK, QCY | DrugDosageText | CC BY-NC | 33976649 | 19,942,359 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | CAPECITABINE, DENOSUMAB, DOXORUBICIN, FULVESTRANT, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976652 | 19,474,178 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemolytic uraemic syndrome'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | CAPECITABINE, DENOSUMAB, DOXORUBICIN, FULVESTRANT, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976652 | 19,474,178 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | ECULIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33976652 | 19,610,224 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Paraneoplastic syndrome'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | CAPECITABINE, DENOSUMAB, DOXORUBICIN, FULVESTRANT, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976652 | 19,474,178 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | ECULIZUMAB, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33976652 | 19,610,224 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombotic microangiopathy'. | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | CAPECITABINE, DENOSUMAB, DOXORUBICIN, FULVESTRANT, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33976652 | 19,474,178 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | UNK UNK, CYCLE, DOSAGE: TWO 3?WEEK CYCLES WERE ADMINISTERED | DrugDosageText | CC BY-NC | 33976652 | 19,610,224 | 2021 |
What was the dosage of drug 'PREDNISOLONE'? | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | 1MG/KG, QD | DrugDosageText | CC BY-NC | 33976652 | 19,474,178 | 2021 |
What was the outcome of reaction 'Death'? | Atypical Evolution of Secondary Hemolytic Uremic Syndrome Defined as Paraneoplastic Syndrome under Eculizumab and Palbociclib Therapies.
Thrombotic microangiopathy (TMA) is most of the time caused by thrombotic thrombocytopenic purpura or hemolytic uremic syndrome. A 60-year-old female was diagnosed in 2014 with mammar... | Fatal | ReactionOutcome | CC BY-NC | 33976652 | 19,474,178 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Stroke due to Left Atrial Appendage Thrombus after Pulmonary Vein Isolation despite Novel Oral Anticoagulant: A Case Report.
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications ... | APIXABAN, ATORVASTATIN CALCIUM, FLUTICASONE, IPRATROPIUM BROMIDE, METOPROLOL, PANTOPRAZOLE SODIUM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 33976660 | 19,744,965 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Stroke due to Left Atrial Appendage Thrombus after Pulmonary Vein Isolation despite Novel Oral Anticoagulant: A Case Report.
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications ... | APIXABAN, ATORVASTATIN CALCIUM, FLUTICASONE, IPRATROPIUM BROMIDE, METOPROLOL, PANTOPRAZOLE SODIUM, RAMIPRIL | DrugsGivenReaction | CC BY-NC | 33976660 | 19,744,965 | 2021 |
What is the weight of the patient? | Stroke due to Left Atrial Appendage Thrombus after Pulmonary Vein Isolation despite Novel Oral Anticoagulant: A Case Report.
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications ... | 93 kg. | Weight | CC BY-NC | 33976660 | 19,744,965 | 2021 |
What was the outcome of reaction 'Cerebrovascular accident'? | Stroke due to Left Atrial Appendage Thrombus after Pulmonary Vein Isolation despite Novel Oral Anticoagulant: A Case Report.
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications ... | Recovering | ReactionOutcome | CC BY-NC | 33976660 | 19,744,965 | 2021 |
What was the outcome of reaction 'Therapy non-responder'? | Stroke due to Left Atrial Appendage Thrombus after Pulmonary Vein Isolation despite Novel Oral Anticoagulant: A Case Report.
In patients with atrial fibrillation, catheter ablation is suggested to reduce the mortality rate and is thus frequently performed. However, peri- and postprocedural thromboembolic complications ... | Recovering | ReactionOutcome | CC BY-NC | 33976660 | 19,744,965 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis aseptic'. | Ibuprofen-Induced Aseptic Meningitis in a Male Adolescent with Intracranial Hypertension and Visual Impairment: A Case Report.
Drug-induced aseptic meningitis (DIAM) is a rare complication of certain drugs, most commonly reported with ibuprofen use. The present study reports on a male adolescent with intracranial hyper... | IBUPROFEN | DrugsGivenReaction | CC BY-NC | 33976661 | 19,445,588 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choroidal neovascularisation'. | Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.
Nonresponse of neovascular age-related macular degeneration (nAMD) to anti-vascular endothelial growth factor (anti-VEGF) therapy can often be attributed to misdiagnosis, and patholog... | SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33976667 | 19,485,922 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.
Nonresponse of neovascular age-related macular degeneration (nAMD) to anti-vascular endothelial growth factor (anti-VEGF) therapy can often be attributed to misdiagnosis, and patholog... | SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33976667 | 19,485,922 | 2021 |
What was the administration route of drug 'SPIRONOLACTONE'? | Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.
Nonresponse of neovascular age-related macular degeneration (nAMD) to anti-vascular endothelial growth factor (anti-VEGF) therapy can often be attributed to misdiagnosis, and patholog... | Oral | DrugAdministrationRoute | CC BY-NC | 33976667 | 19,485,922 | 2021 |
What was the outcome of reaction 'Choroidal neovascularisation'? | Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.
Nonresponse of neovascular age-related macular degeneration (nAMD) to anti-vascular endothelial growth factor (anti-VEGF) therapy can often be attributed to misdiagnosis, and patholog... | Recovering | ReactionOutcome | CC BY-NC | 33976667 | 19,485,922 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal detachment'. | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | FOSCARNET, PREDNISONE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33976676 | 19,437,157 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Retinal tear'. | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | FOSCARNET, PREDNISONE, VALACYCLOVIR HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33976676 | 19,437,157 | 2021 |
What was the administration route of drug 'PREDNISONE'? | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | Oral | DrugAdministrationRoute | CC BY-NC | 33976676 | 19,437,157 | 2021 |
What was the dosage of drug 'FOSCARNET'? | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | 24MG/0.1ML | DrugDosageText | CC BY-NC | 33976676 | 19,437,157 | 2021 |
What was the dosage of drug 'PREDNISONE'? | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | 30 mg (milligrams). | DrugDosage | CC BY-NC | 33976676 | 19,437,157 | 2021 |
What was the dosage of drug 'VALACYCLOVIR HYDROCHLORIDE'? | The Diagnostic Conundrum of Retinitis and a Pigmented Scar.
We report a finding of a pigmented chorioretinal scar with acute retinal necrosis (ARN) caused by herpes simplex virus 2 (HSV-2) infection rather than toxoplasma, creating an initial diagnostic dilemma. A 53-year-old functionally monocular male presented with ... | 2 g (grams). | DrugDosage | CC BY-NC | 33976676 | 19,437,157 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraocular pressure increased'. | Combined Post-Traumatic Total Aniridia and Glaucoma Management.
We report a novel approach for managing traumatic total aniridia associated with secondary glaucoma. A 65-year-old male with symptoms of blurred vision, glare, and photophobia was managed in a district general hospital for post-traumatic aniridia associate... | DEXAMETHASONE, DORZOLAMIDE\TIMOLOL | DrugsGivenReaction | CC BY-NC | 33976683 | 19,416,585 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Combined Post-Traumatic Total Aniridia and Glaucoma Management.
We report a novel approach for managing traumatic total aniridia associated with secondary glaucoma. A 65-year-old male with symptoms of blurred vision, glare, and photophobia was managed in a district general hospital for post-traumatic aniridia associate... | DEXAMETHASONE, DORZOLAMIDE\TIMOLOL | DrugsGivenReaction | CC BY-NC | 33976683 | 19,416,585 | 2021 |
What was the outcome of reaction 'Intraocular pressure increased'? | Combined Post-Traumatic Total Aniridia and Glaucoma Management.
We report a novel approach for managing traumatic total aniridia associated with secondary glaucoma. A 65-year-old male with symptoms of blurred vision, glare, and photophobia was managed in a district general hospital for post-traumatic aniridia associate... | Recovered | ReactionOutcome | CC BY-NC | 33976683 | 19,416,585 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Interstitial lung disease'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | ETANERCEPT, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,384,941 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lower respiratory tract infection'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, OXYGEN, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,650,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, OXYGEN, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,650,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, OXYGEN, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,650,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | ETANERCEPT, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,384,941 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory tract infection'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | ETANERCEPT, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,384,941 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rheumatoid arthritis'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | ETANERCEPT, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,384,941 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper respiratory tract infection'. | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE, OXYGEN, PREDNISONE, RITUXIMAB, TOCILIZUMAB, TOFACITINIB | DrugsGivenReaction | CC BY | 33976699 | 19,650,952 | 2021 |
What was the administration route of drug 'TOCILIZUMAB'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Subcutaneous | DrugAdministrationRoute | CC BY | 33976699 | 19,650,952 | 2021 |
What was the dosage of drug 'ETANERCEPT'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | 50 mg (milligrams). | DrugDosage | CC BY | 33976699 | 19,384,941 | 2021 |
What was the outcome of reaction 'Interstitial lung disease'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovering | ReactionOutcome | CC BY | 33976699 | 19,384,941 | 2021 |
What was the outcome of reaction 'Lower respiratory tract infection'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovered | ReactionOutcome | CC BY | 33976699 | 19,650,952 | 2021 |
What was the outcome of reaction 'Rebound effect'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovering | ReactionOutcome | CC BY | 33976699 | 19,384,941 | 2021 |
What was the outcome of reaction 'Respiratory tract infection'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovered | ReactionOutcome | CC BY | 33976699 | 19,384,941 | 2021 |
What was the outcome of reaction 'Rheumatoid arthritis'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovering | ReactionOutcome | CC BY | 33976699 | 19,384,941 | 2021 |
What was the outcome of reaction 'Upper respiratory tract infection'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovered | ReactionOutcome | CC BY | 33976699 | 19,650,952 | 2021 |
What was the outcome of reaction 'Urinary tract infection'? | Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by chronic symmetrical erosive synovitis and extra-articular manifestations, including interstitial lung disease (ILD), whose treatment is... | Recovered | ReactionOutcome | CC BY | 33976699 | 19,650,952 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chylothorax'. | Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
Dasatinib is a potent and effective second-generation oral tyrosine kinase inhibitor that is clinically indicated for the treatment of imatinib-resistant or imatinib-intolerant breakpoint cluster region-Abels... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33976882 | 19,439,649 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Dasatinib-induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review.
Dasatinib is a potent and effective second-generation oral tyrosine kinase inhibitor that is clinically indicated for the treatment of imatinib-resistant or imatinib-intolerant breakpoint cluster region-Abels... | DASATINIB | DrugsGivenReaction | CC BY-NC | 33976882 | 19,439,649 | 2021-06 |
What was the administration route of drug 'COPPER OR LEVONORGESTREL'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Intra-uterine | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 19,433,421 | 2021-06 |
What was the administration route of drug 'ELEXACAFTOR\IVACAFTOR\TEZACAFTOR'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 19,433,421 | 2021-06 |
What was the administration route of drug 'ETHINYL ESTRADIOL\FERROUS FUMARATE\NORETHINDRONE ACETATE'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 20,881,987 | 2021-06 |
What was the administration route of drug 'ETHINYL ESTRADIOL\NORETHINDRONE'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 19,463,377 | 2021-06 |
What was the administration route of drug 'IVACAFTOR\TEZACAFTOR'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 19,433,418 | 2021-06 |
What was the administration route of drug 'LEVONORGESTREL'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Intra-uterine | DrugAdministrationRoute | CC BY-NC-ND | 33976884 | 19,461,818 | 2021-06 |
What was the dosage of drug 'AMINOCAPROIC ACID'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | UNK (LOW-DOSE) | DrugDosageText | CC BY-NC-ND | 33976884 | 20,881,987 | 2021-06 |
What was the dosage of drug 'ETHINYL ESTRADIOL\FERROUS FUMARATE\NORETHINDRONE ACETATE'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | ORAL CONTRACEPTIVE PILL (OCP), 1.5 MG/30 MCG; INITIATED ON A THREE-WEEK ROTATING CYCLE WITH A SKIPPE | DrugDosageText | CC BY-NC-ND | 33976884 | 20,881,987 | 2021-06 |
What was the outcome of reaction 'Haemoptysis'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Recovering | ReactionOutcome | CC BY-NC-ND | 33976884 | 19,433,418 | 2021-06 |
What was the outcome of reaction 'Heavy menstrual bleeding'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Recovered | ReactionOutcome | CC BY-NC-ND | 33976884 | 19,461,818 | 2021-06 |
What was the outcome of reaction 'Pulmonary embolism'? | Catamenial haemoptysis in females with cystic fibrosis: a case series with review of management strategies.
Catamenial haemoptysis, the expectoration of blood during menses, has not been extensively reported in the cystic fibrosis (CF) literature. We describe four cases (age range: 25-34 years) of catamenial haemoptysi... | Recovered | ReactionOutcome | CC BY-NC-ND | 33976884 | 19,463,377 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | AZACITIDINE, TACROLIMUS | DrugsGivenReaction | CC BY | 33976945 | 19,332,395 | 2021 |
What was the administration route of drug 'AZACITIDINE'? | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | Subcutaneous | DrugAdministrationRoute | CC BY | 33976945 | 19,508,144 | 2021 |
What was the administration route of drug 'TACROLIMUS'? | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | Topical | DrugAdministrationRoute | CC BY | 33976945 | 19,508,144 | 2021 |
What was the outcome of reaction 'Constipation'? | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | Recovered | ReactionOutcome | CC BY | 33976945 | 19,332,395 | 2021 |
What was the outcome of reaction 'Malaise'? | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | Recovered | ReactionOutcome | CC BY | 33976945 | 19,332,395 | 2021 |
What was the outcome of reaction 'Septic shock'? | Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine.
Myeloid sarcoma (MS), which involves extramedullary lesions, is classified as a unique subtype of acute myeloid leukemia (AML). At present, no standard treatments for MS have been established. The ... | Recovered | ReactionOutcome | CC BY | 33976945 | 19,332,395 | 2021 |
What was the dosage of drug 'LITHIUM SULFATE'? | Protracted Hiccups Induced by Aripiprazole and Regressed after Administration of Gabapentin.
Hiccups are sudden, repeated, and involuntary contractions of the diaphragm muscle (myoclonic contraction). It involves a reflex arc that, once activated, causes a strong contraction of the diaphragm immediately followed by the... | INTRODUCED ON THE FIRST DAY | DrugDosageText | CC BY | 33976948 | 19,423,970 | 2021 |
What was the outcome of reaction 'Hiccups'? | Protracted Hiccups Induced by Aripiprazole and Regressed after Administration of Gabapentin.
Hiccups are sudden, repeated, and involuntary contractions of the diaphragm muscle (myoclonic contraction). It involves a reflex arc that, once activated, causes a strong contraction of the diaphragm immediately followed by the... | Recovered | ReactionOutcome | CC BY | 33976948 | 19,362,684 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumocystis jirovecii pneumonia'. | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, REMDESIVIR, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33977081 | 19,374,121 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia cytomegaloviral'. | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, REMDESIVIR, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY-NC-ND | 33977081 | 19,374,121 | 2021 |
What was the administration route of drug 'GANCICLOVIR'? | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33977081 | 19,470,652 | 2021 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33977081 | 19,470,652 | 2021 |
What was the dosage of drug 'BICTEGRAVIR'? | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33977081 | 19,470,652 | 2021 |
What was the dosage of drug 'EMTRICITABINE'? | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33977081 | 19,470,652 | 2021 |
What was the dosage of drug 'GANCICLOVIR'? | Co-infection with coronavirus disease 2019, previously undiagnosed human immunodeficiency virus, Pneumocystis jirovecii pneumonia and cytomegalovirus pneumonitis, with possible immune reconstitution inflammatory syndrome.
Case reports, case series and cohort studies have been published describing the clinical course an... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33977081 | 19,470,652 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.